Investigating the Impact of Smoking in the Post-COVID-19 Era on Young People: DNA Damage Analysis Using the Comet Assay
Archives of Advances in Biosciences,
Vol. 16 No. 1 (2025),
2 Esfand 2025
,
Page 1-9
https://doi.org/10.22037/aab.v16i1.50781
Abstract
Background and Aim: The COVID-19 pandemic not only challenged immune and respiratory systems but also reshaped health-related behaviors, including tobacco use. Increasing evidence suggests that cigarette smoking exacerbates oxidative stress and genomic instability in COVID-19 patients. This study aimed to investigate the impact of smoking on DNA damage among young adults in the post-COVID-19 period using the Comet Assay technique.
Methods: This analytical study included 45 male COVID-19 patients (under 60 years old) who were active or former smokers and were hospitalized in May 2024 at a university-affiliated hospital in Sari, Iran. A comparison group consisted of 42 age-matched non-smoking COVID-19 patients, and 25 healthy non-smoking, non-infected individuals served as the control group. Peripheral blood samples were collected from all participants, and DNA damage in leukocytes was assessed by Single Cell Gel Electrophoresis (Comet Assay). Statistical analyses were performed to compare the extent of DNA damage among groups.
Results: The results showed a significant increase in DNA damage indices—including tail length and tail DNA percentage—in smoking COVID-19 patients compared with both non-smoking patients and healthy controls (p < 0.001). Former smokers also exhibited elevated but comparatively lower levels of DNA damage. These findings suggest that cigarette smoking, even after recovery from COVID-19, can exacerbate oxidative stress and impair DNA repair mechanisms, leading to persistent genomic instability. The Comet Assay proved to be a sensitive and valuable biomarker for detecting subtle DNA damage and monitoring post-viral cellular health.
Conclusion: Smoking remains a significant contributor to genomic injury in young adults recovering from COVID-19.
- COVID 19
- Smoking
- DNA Damage
- Comet Assay
- Post COVID 19
- Genomic Instability
How to Cite
References
[1] Harutyunyan T, Sargsyan A, Kalashyan L, Stepanyan N, Aroutiounian R, Liehr T, et al. DNA damage in moderate and severe COVID-19 cases: relation to demographic, clinical, and laboratory parameters. Int J Mol Sci. 2024;25(19):10293. [DOI: 10.3390/ijms251910293] [PMID]
[2] Basaran MM, Hazar M, Aydın M, Uzuğ G, Özdoğan İ, Pala E, et al. Effects of COVID-19 disease on DNA damage, oxidative stress and immune responses. Toxics. 2023;11(4):386. [DOI: 10.3390/toxics11040386] [PMID]
[3] Olsen MB, Huse C, Sousa MM, Murphy SL, Sarno A, Obermann TS, et al. DNA repair mechanisms are activated in circulating lymphocytes of hospitalized COVID-19 patients. J Inflamm Res. 2022;15:6629-44. [DOI: 10.2147/JIR.S379331] [PMID]
[4] Hong P, Waldenberger M, Pritsch M, Gilberg L, Brand I, Bruger J, et al. Differential DNA methylation 7 months after SARS-CoV-2 infection. Clin Epigenetics. 2025;17(1):60. [DOI: 10.1186/s13148-025-01866-4] [PMID]
[5] Bowsher R, Marczylo TH, Gooch K, Bailey A, Wright MD, Marczylo EL. Smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity: a systematic review and meta-analysis. Eur Respir J. 2024;64(1):2400133. [DOI: 10.1183/13993003.00133-2024] [PMID]
[6] Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S. Smoking, SARS-CoV-2 and COVID-19: a review of reviews considering implications for public health policy and practice. Tob Induc Dis. 2020;18:58. [DOI: 10.18332/tid/124788] [PMID]
[7] Engin AB, Engin ED, Engin A. Two important controversial risk factors in SARS-CoV-2 infection: obesity and smoking. Environ Toxicol Pharmacol. 2020;78:103411. [DOI: 10.1016/j.etap.2020.103411] [PMID]
[8] Kaur G, Lungarella G, Rahman I. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping. J Inflamm (Lond). 2020;17:21. [DOI: 10.1186/s12950-020-00250-8] [PMID]
[9] Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2021;116(6):1319-68. [DOI: 10.1111/add.15276] [PMID]
[10] Prinelli F, Bianchi F, Drago G, Ruggieri S, Sojic A, Jesuthasan N, et al. Association between smoking and SARS-CoV-2 infection: cross-sectional study of the EPICOVID19 internet-based survey. JMIR Public Health Surveill. 2021;7(4):e27091. [DOI: 10.2196/27091] [PMID]
[11] Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (COVID-19). J Clin Med. 2020;9(3):841. [DOI: 10.3390/jcm9030841] [PMID]
[12] Gupta I, Sohail MU, Elzawawi KE, Amarah AH, Vranic S, Al-Asmakh M, et al. SARS-CoV-2 infection and smoking: what is the association? A brief review. Comput Struct Biotechnol J. 2021;19:1654-60. [DOI: 10.1016/j.csbj.2021.03.023] [PMID]
[13] Benowitz NL, Goniewicz ML, Halpern-Felsher B, Krishnan-Sarin S, Ling PM, O'Connor RJ, et al. Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research. Lancet Respir Med. 2022;10(9):900-15. [DOI: 10.1016/S2213-2600(22)00182-5] [PMID]
[14] van Westen-Lagerweij NA, Meijer E, Meeuwsen EG, Chavannes NH, Willemsen MC, Croes EA. Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth. NPJ Prim Care Respir Med. 2021;31(1):10. [DOI: 10.1038/s41533-021-00223-1] [PMID]
[15] Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract. Dev Cell. 2020;53(5):514-529.e3. [DOI: 10.1016/j.devcel.2020.05.012] [PMID]
[16] Young-Wolff KC, Slama N, Alexeeff SE, Sakoda LC, Fogelberg R, Myers LC, et al. Tobacco smoking and risk of SARS-CoV-2 infection and disease severity among adults in an integrated healthcare system in California. Nicotine Tob Res. 2023;25(2):211-20. [DOI: 10.1093/ntr/ntac090] [PMID]
[17] Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM. Smoking-mediated upregulation of the androgen pathway leads to increased SARS-CoV-2 susceptibility. Int J Mol Sci. 2020;21(10):3627. [DOI: 10.3390/ijms21103627] [PMID]
[18] Sharif-Askari NS, Sharif-Askari FS, Alabed M, Temsah MH, Al Heialy S, Hamid Q, et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol Ther Methods Clin Dev. 2020;18:1-6. [DOI: 10.1016/j.omtm.2020.05.013] [PMID]
[19] Yin J, Kasper B, Petersen F, Yu X. Association of cigarette smoking, COPD, and lung cancer with expression of SARS-CoV-2 entry genes in human airway epithelial cells. Front Med (Lausanne). 2020;7:619453. [DOI: 10.3389/fmed.2020.619453] [PMID]
[20] Purkayastha A, Sen C, Garcia G Jr, Langerman J, Shia DW, Meneses LK, et al. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response. Cell Stem Cell. 2020;27(6):869-875.e4. [DOI: 10.1016/j.stem.2020.11.010] [PMID]
[21] Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv [Preprint]. 2020 Apr 20:2020.04.19.049254. [DOI: 10.1101/2020.04.19.049254]
[22] Samet JM. Tobacco products and the risks of SARS-CoV-2 infection and COVID-19. Nicotine Tob Res. 2020;22(12 Suppl 2):S93-5. [DOI: 10.1093/ntr/ntaa187] [PMID]
[23] Tomchaney M, Contoli M, Mayo J, Baraldo S, Li S, Cabel CR, et al. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med. 2021;21(1):275. [DOI: 10.1186/s12890-021-01639-8] [PMID]
[24] Liu A, Zhang X, Li R, Zheng M, Yang S, Dai L, et al. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia. J Pathol. 2021;253(1):17-30. [DOI: 10.1002/path.5555] [PMID]
[25] Rossato M, Russo L, Mazzocut S, Di Vincenzo A, Fioretto P, Vettor R. Current smoking is not associated with COVID-19. Eur Respir J. 2020;55(6):2001290. [DOI: 10.1183/13993003.01290-2020] [PMID]
[26] Korzeniowska A, Ręka G, Bilska M, Piecewicz-Szczęsna H. The smoker's paradox during the COVID-19 pandemic? The influence of smoking and vaping on the incidence and course of SARS-CoV-2 virus infection as well as possibility of using nicotine in the treatment of COVID-19 - review of the literature. Przegl Epidemiol. 2021;75(1):27-44. [DOI: 10.32394/pe.75.03] [PMID]
[27] Kramer I, Zhu Y, van Westen-Lagerweij NA, Dekker LH, Mierau JO, Croes EA. New insights into the paradox between smoking and the risk of SARS-CoV-2 infection (COVID-19): insufficient evidence for a causal association. Scand J Public Health. 2025;53(5):552-9. [DOI: 10.1177/14034948241253690] [PMID]
[28] Garufi G, Carbognin L, Orlandi A, Tortora G, Bria E. Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: the unsolved paradox behind the evidence. Eur J Intern Med. 2020;77:121-2. [DOI: 10.1016/j.ejim.2020.04.042] [PMID]
[29] Bektemur G, Bozali K, Colak S, Aktas S, Guler EM. Oxidative stress, DNA damage, and inflammation in COVID-19 patients. North Clin Istanb. 2023;10(3):335-40. [DOI: 10.14744/nci.2022.00947] [PMID]
[30] Fatima S, Yadam S. The comet assay: a straight way to estimate geno-toxicity. 21st Century Pathol. 2023;3(2):145. [LINK]
[31] Alshammari MA, Alamer A, Al Lehaibi L, Alghamdi M, Alotaibi H, Alomar M, et al. Association between COVID-19 severity and tobacco smoking status: a retrospective cohort study using propensity score matching weights analysis. BMJ Open Respir Res. 2024;11(1):e001976. [DOI: 10.1136/bmjresp-2023-001976] [PMID]
[32] Salehi Z, Motlagh Ghoochani BF, Hasani Nourian Y, Jamalkandi SA, Ghanei M. The controversial effect of smoking and nicotine in SARS-CoV-2 infection. Allergy Asthma Clin Immunol. 2023;19(1):49. [DOI: 10.1186/s13223-023-00797-0] [PMID]
[33] Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tob Induc Dis. 2020;18:60. [DOI: 10.18332/tid/123845] [PMID]
[34] Cattaruzza MS, Zagà V, Gallus S, D'Argenio P, Gorini G. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Acta Biomed. 2020;91(2):106-12. [DOI: 10.23750/abm.v91i2.9698] [PMID]
[35] Sadr FE, Abadi Z, Sadr NE, Fard MM. The risk for SARS-CoV-2 virus contamination through surgical smoking and aerosolization by laparoscopic surgery: a systematic review. Ann Romanian Soc Cell Biol. 2021;25(1):6839-52. [LINK]
- Abstract Viewed: 107 times
- PDF Downloaded: 16 times